Search Ontology:
ChEBI

ASP-3026

Term ID
CHEBI:167650
Synonyms
  • 2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]-4-N-(2-propan-2-ylsulfonylphenyl)-1,3,5-triazine-2,4-diamine
  • ASP 3026
  • ASP3026
  • N(2)-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N(4)-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine
  • N-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}-N'-[2-(propan-2-ylsulfonyl)phenyl]-1,3,5-triazine-2,4-diamine
Definition
A member of the class of diamino-1,3,5-triazines that is 1,3,5-triazine-2,4-diamine in which the amino groups at positions 2 and 4 are respectively carrying 2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl and 2-(propan-2-ylsulfonyl)phenyl substituents. It is a potent inhibitor of anaplastic lymphoma kinase (ALK), Ack and ROS1 activity (IC50 values are 3.5, 5.8 and 8.9 nM respectively) and exhibits anti-cancer properties.
References
  • cas:1097917-15-1
  • chemspider:28424239
  • drugbank:DB12729
  • pdb-ccd:F6O
  • pubmed:24419060
  • pubmed:25026277
  • pubmed:25727400
  • pubmed:25749034
  • pubmed:25888090
  • pubmed:26020125
  • pubmed:26027465
  • pubmed:26964870
  • pubmed:26966027
  • pubmed:27565932
  • pubmed:28930717
  • pubmed:29491259
  • pubmed:31177400
  • pubmed:31340850
  • pubmed:33053158
  • pubmed:33331996
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from ASP-3026
Phenotype where environments contain ASP-3026
Phenotype modified by environments containing ASP-3026
Phenotype affecting ASP-3026
Human Disease Model